{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T14:07:36Z","timestamp":1791295656570,"version":"4.1.0"},"reference-count":91,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2013,2,2]],"date-time":"2013-02-02T00:00:00Z","timestamp":1359763200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/2.5"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["CNS Drugs"],"published-print":{"date-parts":[[2013,3]]},"DOI":"10.1007\/s40263-013-0040-7","type":"journal-article","created":{"date-parts":[[2013,2,1]],"date-time":"2013-02-01T18:06:22Z","timestamp":1359741982000},"page":"165-173","source":"Crossref","is-referenced-by-count":68,"title":["Genetic Influences on Response to Mood Stabilizers in Bipolar Disorder"],"prefix":"10.1007","volume":"27","author":[{"given":"Janusz K.","family":"Rybakowski","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,2,2]]},"reference":[{"key":"40_CR1","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1002\/9780470976739.ch19","volume-title":"Textbook in psychiatric epidemiology","author":"KR Merinkangas","year":"2011","unstructured":"Merinkangas KR, Tohen M. Epidemiology of bipolar disorder in adults and children. In: Tsuang MT, Tohen MT, Jones PB, editors. Textbook in psychiatric epidemiology. Chichester: John Wiley and Sons; 2011. p. 329\u201342."},{"issue":"Suppl. 1","key":"40_CR2","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1034\/j.1399-5618.4.s1.3.x","volume":"4","author":"Z Rihmer","year":"2002","unstructured":"Rihmer Z, Kiss K. Bipolar disorders and suicidal behavior. Bipolar Disord. 2002;4(Suppl. 1):21\u20135.","journal-title":"Bipolar Disord"},{"key":"40_CR3","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1001\/archpsyc.60.5.497","volume":"60","author":"P McGuffin","year":"2003","unstructured":"McGuffin P, Rijsdijk F, Andrew M, et al. The heritability of bipolar affective disorder and the genetic relationship to bipolar depression. Arch Gen Psychiatry. 2003;60:497\u2013502.","journal-title":"Arch Gen Psychiatry"},{"key":"40_CR4","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1017\/S146114570700795X","volume":"10","author":"JK Rybakowski","year":"2007","unstructured":"Rybakowski JK. Two generations of mood stabilizers. Int J Neuropsychopharmacol. 2007;10:709\u201311.","journal-title":"Int J Neuropsychopharmacol"},{"key":"40_CR5","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1192\/bjp.109.463.810","volume":"109","author":"G Hartigan","year":"1963","unstructured":"Hartigan G. The use of lithium salts in affective disorders. Br J Psychiatry. 1963;109:810\u20134.","journal-title":"Br J Psychiatry"},{"key":"40_CR6","first-page":"442","volume":"2","author":"PA Lambert","year":"1971","unstructured":"Lambert PA, Borselli S, Marcou G, et al. Long-term thymoregulative action of Depamide in manic-depressive psychoses [in French]. Ann Med Psychol. 1971;2:442\u20137.","journal-title":"Ann Med Psychol"},{"key":"40_CR7","first-page":"283","volume":"27","author":"T Okuma","year":"1973","unstructured":"Okuma T, Kishimoto A, Inue K. Anti-manic and prophylactic effect of carbamazepine (Tegretol) on manic depressive psychosis. Folia Psychiatr Neurol Japan. 1973;27:283\u201397.","journal-title":"Folia Psychiatr Neurol Japan"},{"key":"40_CR8","first-page":"108","volume":"56","author":"CA Zarate","year":"1995","unstructured":"Zarate CA. Is clozapine a mood stabilizer? J Clin Psychiatry. 1995;56:108\u201312.","journal-title":"J Clin Psychiatry"},{"key":"40_CR9","doi-asserted-by":"crossref","first-page":"862","DOI":"10.4088\/JCP.v69n0522b","volume":"69","author":"JK Rybakowski","year":"2008","unstructured":"Rybakowski JK. Aripiprazole joins the family of second-generation mood stabilizers. J Clin Psychiatry. 2008;69:862\u20133.","journal-title":"J Clin Psychiatry"},{"key":"40_CR10","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.biopsych.2010.01.015","volume":"68","author":"JA Quiroz","year":"2010","unstructured":"Quiroz JA, Yatham LN, Palumbo JM, et al. Risperidone long-acting injectable monotherapy in the maintenence treatment of bipolar disorder. Biol Psychiatry. 2010;68:156\u201362.","journal-title":"Biol Psychiatry"},{"key":"40_CR11","doi-asserted-by":"crossref","first-page":"146","DOI":"10.4088\/JCP.v63n0210","volume":"63","author":"T Ketter","year":"2002","unstructured":"Ketter T, Calabrese JR. Stabilization of mood from below versus above baseline in bipolar disorder: a new nomenclature. J Clin Psychiatry. 2002;63:146\u201351.","journal-title":"J Clin Psychiatry"},{"key":"40_CR12","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.jad.2006.01.032","volume":"93","author":"F Colom","year":"2006","unstructured":"Colom F, Vieta E, Daban C, et al. Clinical and therapeutic implications of predominant polarity in bipolar disorder. J Affect Disord. 2006;93:13\u20137.","journal-title":"J Affect Disord"},{"key":"40_CR13","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1111\/j.1755-5949.2011.00258.x","volume":"18","author":"E Severus","year":"2012","unstructured":"Severus E, Schaaff N, M\u00f6ller HJ. State of the art: treatment of bipolar disorders. CNS Neurosci Ther. 2012;18:214\u20138.","journal-title":"CNS Neurosci Ther"},{"key":"40_CR14","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.euroneuro.2011.09.008","volume":"22","author":"D Popovic","year":"2012","unstructured":"Popovic D, Reinares M, Goikolea JM, et al. Polarity index of pharmacological agents used for maintenance treatment of bipolar disorder. Eur Neuropharmacol. 2012;22:339\u201346.","journal-title":"Eur Neuropharmacol"},{"key":"40_CR15","doi-asserted-by":"crossref","first-page":"349","DOI":"10.5694\/j.1326-5377.1949.tb36912.x","volume":"2","author":"J Cade","year":"1949","unstructured":"Cade J. Lithium salts in the treatment of psychotic excitement. Med J Aust. 1949;2:349\u201352.","journal-title":"Med J Aust"},{"key":"40_CR16","first-page":"36","volume-title":"Lithium: 50\u00a0years of psychopharmacology, new perspectives in biomedical and clinical research","author":"P Grof","year":"1999","unstructured":"Grof P. Excellent lithium responders: people whose lives have been changed by lithium prophylaxis. In: Birch NJ, Gallicchio VS, Becker RW, editors. Lithium: 50\u00a0years of psychopharmacology, new perspectives in biomedical and clinical research. Cheshire (CT): Weidner Publishing Group; 1999. p. 36\u201351."},{"key":"40_CR17","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1034\/j.1399-5618.2001.030203.x","volume":"3","author":"JK Rybakowski","year":"2001","unstructured":"Rybakowski JK, Ch\u0142opocka-Wo\u017aniak M, Suwalska A. The prophylactic effect of long-term lithium administration in bipolar patients entering lithium treatment in the 1970s and 1980s. Bipolar Disord. 2001;3:63\u20137.","journal-title":"Bipolar Disord"},{"key":"40_CR18","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1159\/000314305","volume":"62","author":"P Grof","year":"2010","unstructured":"Grof P. Sixty years of lithium responders. Neuropsychobiology. 2010;62:27\u201335.","journal-title":"Neuropsychobiology"},{"key":"40_CR19","unstructured":"Kraepelin E. Psychiatrie. Ein Lehrbuch f\u00fcr Studierende und \u00c4rzte. Barth, Leipzig: 6 Auflage, 1899."},{"key":"40_CR20","doi-asserted-by":"crossref","unstructured":"Rybakowski JK, Dembinska D, Kliwicki S, et al. TEMPS-A and long-term lithium response: positive correlation with hyperthymic temperament. J Affect Disord. Epub 28 Aug 2012.","DOI":"10.1016\/j.jad.2012.07.028"},{"issue":"Suppl. 1","key":"40_CR21","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1159\/000054844","volume":"42","author":"N Kleindienst","year":"2000","unstructured":"Kleindienst N, Greil W. Differential efficacy of lithium and carbamazepine in the prophylaxis of bipolar disorder: results of the MAP study. Neuropsychobiology. 2000;42(Suppl. 1):2\u201310.","journal-title":"Neuropsychobiology"},{"key":"40_CR22","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1176\/ajp.146.1.81","volume":"146","author":"AJ Kessler","year":"1989","unstructured":"Kessler AJ, Barklage NE, Jefferson JW. Mood disorders in the psychoneurologic borderland: three cases of responsiveness to carbamazepine. Am J Psychiatry. 1989;146:81\u20133.","journal-title":"Am J Psychiatry"},{"key":"40_CR23","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1034\/j.1399-5618.2003.00026.x","volume":"5","author":"MJ Passmore","year":"2003","unstructured":"Passmore MJ, Garnham J, Duffy A, et al. Phenotypic spectra of bipolar disorder in responders to lithium versus lamotrigine. Bipolar Disord. 2003;5:110\u20134.","journal-title":"Bipolar Disord"},{"key":"40_CR24","first-page":"411","volume":"56","author":"CA Zarate","year":"1995","unstructured":"Zarate CA, Tohen M, Baldessarini RJ. Clozapine in severe mood disorders. J Clin Psychiatry. 1995;56:411\u20137.","journal-title":"J Clin Psychiatry"},{"key":"40_CR25","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1055\/s-2005-871239","volume":"38","author":"JK Rybakowski","year":"2005","unstructured":"Rybakowski JK, Suwalska A, Skibinska M, et al. Prophylactic lithium response and polymorphism of the brain-derived neurotrophic factor gene. Pharmacopsychiatry. 2005;38:166\u201370.","journal-title":"Pharmacopsychiatry"},{"key":"40_CR26","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1002\/ajmg.10357","volume":"144","author":"A Serretti","year":"2002","unstructured":"Serretti A, Lorenzi C, Lilli R, et al. Pharmacogenetics of lithium prophylaxis in mood disorders: analysis of COMT, MAO-A, and G\u00df3 variants. Am J Med Genet Part B Neuropsychiatr Genet. 2002;144:370\u20139.","journal-title":"Am J Med Genet Part B Neuropsychiatr Genet"},{"key":"40_CR27","doi-asserted-by":"crossref","first-page":"942","DOI":"10.4088\/JCP.v63n1013","volume":"63","author":"P Grof","year":"2002","unstructured":"Grof P, Duffy A, Cavazzoni P, et al. Is response to prophylactic lithium a familial trait? J Clin Psychiatry. 2002;63:942\u20137.","journal-title":"J Clin Psychiatry"},{"key":"40_CR28","doi-asserted-by":"crossref","first-page":"79.1","DOI":"10.1186\/gm79","volume":"1","author":"C Cruceanu","year":"2009","unstructured":"Cruceanu C, Alda M, Turecki G. Lithium: a key to the genetics of bipolar disorder. Genome Med. 2009;1:79.1\u20137.","journal-title":"Genome Med"},{"key":"40_CR29","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.2217\/pgs.10.127","volume":"11","author":"MJ McCarthy","year":"2010","unstructured":"McCarthy MJ, Leckband SG, Kelsoe JR. Pharmacogenetics of lithium response in bipolar disorder. Pharmacogenomics. 2010;11:1439\u201365.","journal-title":"Pharmacogenomics"},{"key":"40_CR30","doi-asserted-by":"crossref","first-page":"142","DOI":"10.3109\/09638230903469103","volume":"19","author":"DJ Smith","year":"2010","unstructured":"Smith DJ, Evans R, Craddock N. Predicting response to lithium in bipolar disorder: a critical review of pharmacogenetic studies. J Ment Health. 2010;19:142\u201356.","journal-title":"J Ment Health"},{"key":"40_CR31","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1159\/000314311","volume":"62","author":"A Serretti","year":"2010","unstructured":"Serretti A, Drago A. Pharmacogenetics of lithium long-term treatment: focus on initiation and adaptation mechanisms. Neuropsychobiology. 2010;62:61\u201371.","journal-title":"Neuropsychobiology"},{"key":"40_CR32","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1055\/s-2007-1017367","volume":"18","author":"B M\u00fcller-Oerlinghausen","year":"1985","unstructured":"M\u00fcller-Oerlinghausen B. Lithium long-term treatment: does it act via serotonin? Pharmacopsychiatry. 1985;18:214\u20137.","journal-title":"Pharmacopsychiatry"},{"key":"40_CR33","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/S0924-9338(03)00026-9","volume":"18","author":"J Hauser","year":"2003","unstructured":"Hauser J, Leszczynska A, Samochowiec J, et al. Association analysis of the insertion\/deletion polymorphism in serotonin transporter gene in patients with affective disorder. Eur Psychiatry. 2003;18:129\u201332.","journal-title":"Eur Psychiatry"},{"key":"40_CR34","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.euroneuro.2011.10.003","volume":"22","author":"S Porcelli","year":"2012","unstructured":"Porcelli S, Fabbri C, Serretti A. Meta-analysis of serotonin transporter gene promoter polymorphism (5-HTTLPR) association with antidepressant efficacy. Eur Neuropsychopharmacol. 2012;22:239\u201358.","journal-title":"Eur Neuropsychopharmacol"},{"key":"40_CR35","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1038\/sj.tpj.6500006","volume":"1","author":"A Serretti","year":"2001","unstructured":"Serretti A, Lilli R, Mandelli L, et al. Serotonin transporter gene associated with lithium prophylaxis in mood disorders. Pharmacogenomics J. 2001;1:71\u20137.","journal-title":"Pharmacogenomics J"},{"key":"40_CR36","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1038\/sj.tpj.6500252","volume":"4","author":"A Serretti","year":"2004","unstructured":"Serretti A, Malitas PN, Mandelli L. Further evidence for a possible association between serotonin transporter gene and lithium prophylaxis in mood disorders. Pharmacogenomics J. 2004;4:267\u201373.","journal-title":"Pharmacogenomics J"},{"key":"40_CR37","first-page":"124","volume":"57","author":"JK Rybakowski","year":"2005","unstructured":"Rybakowski JK, Suwalska A, Czerski PM, et al. Prophylactic effect of lithium in bipolar affective illness may be related to serotonin transporter genotype. Pharmacol Rep. 2005;57:124\u20137.","journal-title":"Pharmacol Rep"},{"key":"40_CR38","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/j.neulet.2006.05.001","volume":"403","author":"L Michelon","year":"2006","unstructured":"Michelon L, Meira-Lima I, Cordeiro Q, et al. Association study of the INPP1, 5HTT, BDNF, AP-2beta and GSK-3beta gene variants and retrospectively scored response to lithium prophylaxis in bipolar disorder. Neurosci Lett. 2006;403:288\u201393.","journal-title":"Neurosci Lett"},{"key":"40_CR39","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.psychres.2008.12.004","volume":"169","author":"M Manchia","year":"2009","unstructured":"Manchia M, Congiu D, Squassina A, et al. No association between lithium full responders and the DRD1, DRD2, DRD3, DAT1, 5-HTTLPR and HTR2A genes in a Sardinian sample. Psychiatry Res. 2009;169:164\u20136.","journal-title":"Psychiatry Res"},{"key":"40_CR40","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/S0022-3956(00)00004-2","volume":"34","author":"A Serretti","year":"2000","unstructured":"Serretti A, Lorenzi C, Lill R, et al. Serotonin receptor 2A, 2C, 1A genes and response to lithium prophylaxis in mood disorders. J Psychiatr Res. 2000;34:89\u201398.","journal-title":"J Psychiatr Res"},{"key":"40_CR41","first-page":"761","volume":"57","author":"M Dmitrzak-Weglarz","year":"2005","unstructured":"Dmitrzak-Weglarz M, Rybakowski JK, Suwalska A, et al. Association studies of 5-HT2A and 5-HT2C serotonin receptor gene polymorphisms with prophylactic lithium response in bipolar patients. Pharmacol Rep. 2005;57:761\u20135.","journal-title":"Pharmacol Rep"},{"key":"40_CR42","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/S0022-3956(99)00013-8","volume":"33","author":"A Serretti","year":"1999","unstructured":"Serretti A, Lilli R, Lorenzi C, et al. Tryptophan hydroxylase gene and response to lithium prophylaxis in mood disorders. J Psychiatr Res. 1999;33:371\u20137.","journal-title":"J Psychiatr Res"},{"key":"40_CR43","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1002\/ajmg.b.30116","volume":"134B","author":"G Severino","year":"2005","unstructured":"Severino G, Congiu D, Serreli C, et al. A48G polymorphism in the D1 receptor genes associated with bipolar I disorder. Am J Med Genet B Neuropsychiatr Genet. 2005;134B:37\u20138.","journal-title":"Am J Med Genet B Neuropsychiatr Genet"},{"key":"40_CR44","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1055\/s-0028-1085441","volume":"42","author":"JK Rybakowski","year":"2009","unstructured":"Rybakowski JK, Dmitrzak-Weglarz M, Suwalska A. Dopamine D1 receptor gene polymorphism is associated with prophylactic lithium response in bipolar disorder. Pharmacopsychiatry. 2009;42:20\u20132.","journal-title":"Pharmacopsychiatry"},{"key":"40_CR45","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1017\/S1461145798001230","volume":"1","author":"A Serretti","year":"1998","unstructured":"Serretti A, Lilli R, Lorenzi C, et al. Dopamine receptor D3 gene and response to lithium prophylaxis in mood disorders. Int J Neuropsychopharmacol. 1998;1:125\u20139.","journal-title":"Int J Neuropsychopharmacol"},{"key":"40_CR46","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/S0165-1781(99)00056-6","volume":"87","author":"A Serretti","year":"1999","unstructured":"Serretti A, Lilli R, Lorenzi C, et al. Dopamine receptor D2 and D4 genes, GABAA alpha-1 subunit genes and response to lithium prophylaxis in mood disorders. Psychiatry Res. 1999;87:7\u201319.","journal-title":"Psychiatry Res"},{"key":"40_CR47","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1097\/00041444-199903000-00003","volume":"9","author":"G Turecki","year":"1999","unstructured":"Turecki G, Grof P, Cavazzoni P, et al. MAOA: association and linkage studies with lithium responsive bipolar disorder. Psychiatr Genet. 1999;9:13\u20136.","journal-title":"Psychiatr Genet"},{"key":"40_CR48","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/S1734-1140(09)70085-4","volume":"61","author":"A Szczepankiewicz","year":"2009","unstructured":"Szczepankiewicz A, Skibinska M, Suwalska A, et al. No association of three GRIN2B polymorphisms with lithium response in bipolar patients. Pharmacol Rep. 2009;61:448\u201352.","journal-title":"Pharmacol Rep"},{"key":"40_CR49","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1159\/000219305","volume":"59","author":"A Szczepankiewicz","year":"2009","unstructured":"Szczepankiewicz A, Rybakowski JK, Skibinska M, et al. FYN kinase gene: another glutamatergic gene associated with bipolar disorder? Neuropsychobiology. 2009;59:178\u201383.","journal-title":"Neuropsychobiology"},{"key":"40_CR50","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1002\/hup.1018","volume":"24","author":"A Szczepankiewicz","year":"2009","unstructured":"Szczepankiewicz A, Skibinska M, Suwalska A, et al. The association study of three FYN polymorphisms with prophylactic lithium response in bipolar patients. Hum Psychopharmacol. 2009;24:287\u201391.","journal-title":"Hum Psychopharmacol"},{"key":"40_CR51","first-page":"259","volume":"8","author":"VM Steen","year":"1998","unstructured":"Steen VM, L\u00f8vlie R, Osher Y, et al. The polymorphic inositol polyphosphate 1-phosphatase gene as a candidate for pharmacogenetic prediction of lithium-responsive manic-depressive illness. Pharmacogenetics. 1998;8:259\u201368.","journal-title":"Pharmacogenetics"},{"key":"40_CR52","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1007\/BF03256238","volume":"11","author":"T Bremer","year":"2007","unstructured":"Bremer T, Diamond C, McKinney R, et al. The pharmacogenetics of lithium response depends upon clinical co-morbidity. Mol Diagn Ther. 2007;11:161\u201370.","journal-title":"Mol Diagn Ther"},{"key":"40_CR53","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1038\/sj.tpj.6500273","volume":"5","author":"A Dimitrova","year":"2005","unstructured":"Dimitrova A, Milanova V, Krastev S, et al. Association study of myo-inositol monophosphatase 2 (IMPA2) polymorphisms with bipolar affective disorder and response to lithium treatment. Pharmacogenomics J. 2005;5:35\u201341.","journal-title":"Pharmacogenomics J"},{"key":"40_CR54","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.neulet.2009.10.003","volume":"467","author":"M Manchia","year":"2009","unstructured":"Manchia M, Squassina A, Congiu D, et al. Interacting genes in lithium prophylaxis: preliminary results of an exploratory analysis on the role of DGKH and NR1D1 gene polymorphisms in 199 Sardinian bipolar patients. Neurosci Lett. 2009;467:67\u201371.","journal-title":"Neurosci Lett"},{"key":"40_CR55","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1002\/ajmg.b.30617","volume":"147B","author":"F Mamdani","year":"2008","unstructured":"Mamdani F, Alda M, Grof P, et al. Lithium response and genetic variation in the CREB family of genes. Am J Med Genet B Neuropsychiatr Genet. 2008;147B:500\u20134.","journal-title":"Am J Med Genet B Neuropsychiatr Genet"},{"key":"40_CR56","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.phrs.2008.03.011","volume":"57","author":"A Squassina","year":"2008","unstructured":"Squassina A, Congiu D, Manconi F, et al. The PDLIM5 gene and lithium prophylaxis: an association and gene expression analysis in Sardinian patients with bipolar disorder. Pharmacol Res. 2008;57:369\u201373.","journal-title":"Pharmacol Res"},{"key":"40_CR57","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1111\/j.1399-5618.2011.00955.x","volume":"13","author":"C Sears","year":"2011","unstructured":"Sears C, Markie D, Olds R, et al. Evidence of associations between bipolar disorder and the brain-derived neurotrophic factor (BDNF) gene. Bipolar Disord. 2011;13:630\u20137.","journal-title":"Bipolar Disord"},{"key":"40_CR58","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.2217\/14622416.9.11.1595","volume":"9","author":"M Dmitrzak-Weglarz","year":"2008","unstructured":"Dmitrzak-Weglarz M, Rybakowski JK, Suwalska A, et al. Association studies of the BDNF and the NTRK2 gene polymorphisms with prophylactic lithium response in bipolar patients. Pharmacogenomics. 2008;9:1595\u2013603.","journal-title":"Pharmacogenomics"},{"key":"40_CR59","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1002\/ajmg.b.30420","volume":"144B","author":"JK Rybakowski","year":"2007","unstructured":"Rybakowski JK, Suwalska A, Skibinska M, et al. Response to lithium prophylaxis: interaction between serotonin transporter and BDNF genes. Am J Med Genet Part B Neuropsychiatr Genet. 2007;144B:820\u20133.","journal-title":"Am J Med Genet Part B Neuropsychiatr Genet"},{"key":"40_CR60","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1097\/01.ypg.0000180680.72922.57","volume":"16","author":"T Masui","year":"2006","unstructured":"Masui T, Hashimoto R, Kusumi I, et al. Lithium response and Val66Met polymorphism of the brain derived neurotrophic factor gene in Japanese patients with bipolar disorder. Psychiatr Genet. 2006;16:49\u201350.","journal-title":"Psychiatr Genet"},{"key":"40_CR61","unstructured":"Leckband SG, DeModena A, McKinney R, et al. Lithium response is associated with the NTRK2 gene in a prospective study. Presented at 17th Annual Molecular Psychiatry Conference; 31 Jan\u20132 Feb 2010; Park City (UT)."},{"key":"40_CR62","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.neulet.2004.11.022","volume":"376","author":"F Benedetti","year":"2005","unstructured":"Benedetti F, Serretti A, Pontigia A, et al. Long-term response to lithium salts in bipolar illness is influenced by the glycogen synthase kinase 3-beta-50T\/C SNP. Neurosci Lett. 2005;376:51\u20135.","journal-title":"Neurosci Lett"},{"key":"40_CR63","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1080\/15622970600554711","volume":"7","author":"A Szczepankiewicz","year":"2006","unstructured":"Szczepankiewicz A, Rybakowski JK, Suwalska A, et al. Association study of the glycogen synthase kinase-3beta gene polymorphism with prophylactic lithium response in bipolar patients. World J Biol Psychiatry. 2006;7:158\u201361.","journal-title":"World J Biol Psychiatry"},{"key":"40_CR64","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1177\/0748730410362713","volume":"25","author":"S Campos-de-Sousa","year":"2010","unstructured":"Campos-de-Sousa S, Guindalini C, Tondo L, et al. Nuclear receptor rev-erb-(alpha) circadian gene variants and lithium carbonate prophylaxis in bipolar affective disorder. J Biol Phythms. 2010;25:132\u20137.","journal-title":"J Biol Phythms"},{"key":"40_CR65","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1111\/j.1601-183X.2011.00725.x","volume":"10","author":"MJ McCarthy","year":"2011","unstructured":"McCarthy MJ, Nievergelt CM, Shenkhtman T, et al. Functional genetic variation in the Rev-Erb\u03b1 pathway and lithium response in the treatment of bipolar disorder. Genes Brain Behav. 2011;10:852\u201361.","journal-title":"Genes Brain Behav"},{"key":"40_CR66","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1007\/s12017-009-8072-3","volume":"11","author":"JK Rybakowski","year":"2009","unstructured":"Rybakowski JK, Skibinska M, Leszczynska-Rodziewicz A, et al. Matrix metalloproteinase-9 (MMP-9) gene and bipolar mood disorder. Neuromolecular Med. 2009;11:128\u201332.","journal-title":"Neuromolecular Med"},{"key":"40_CR67","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1002\/hup.1182","volume":"26","author":"JK Rybakowski","year":"2011","unstructured":"Rybakowski JK, Skibinska M, Suwalska A, et al. Functional polymorphism of matrix metalloproteinase-9 (MMP-9) gene and response to lithium prophylaxis in bipolar patients. Hum Psychopharmacol. 2011;26:168\u201371.","journal-title":"Hum Psychopharmacol"},{"key":"40_CR68","first-page":"545","volume":"32","author":"A Szczepankiewicz","year":"2011","unstructured":"Szczepankiewicz A, Rybakowski JK, Suwalska A, et al. Glucocorticoid receptor polymorphism is associated with lithium response in bipolar patients. Neuro Endocrinol Lett. 2011;32:545\u201351.","journal-title":"Neuro Endocrinol Lett"},{"issue":"Suppl. 1","key":"40_CR69","doi-asserted-by":"crossref","first-page":"S4","DOI":"10.1016\/S0924-977X(11)70004-9","volume":"21","author":"PM Czerski","year":"2011","unstructured":"Czerski PM, Kliwicki S, Maciukiewicz M, et al. Multiple single nucleotide polymorphisms of schizophrenia-related DISC1 gene in lithium-treated patients with bipolar affective disorder. Eur Neuropsychopharmacol. 2011;21(Suppl. 1):S4\u20135.","journal-title":"Eur Neuropsychopharmacol"},{"key":"40_CR70","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.pnpbp.2007.08.010","volume":"32","author":"T Masui","year":"2008","unstructured":"Masui T, Hashimoto R, Kusumi I, et al. A possible association between missense polymorphism of the breakpoint cluster region gene and lithium prophylaxis in bipolar disorder. Prog Neuropsychopharmacol Biol Psychiatry. 2008;32:204\u20138.","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"40_CR71","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1017\/S1461145705005523","volume":"9","author":"T Masui","year":"2006","unstructured":"Masui T, Hashimoto R, Kusumi I, et al. A possible association between the \u2212116C\/G single nucleotide polymorphism of the XBP1 gene and lithium prophylaxis in bipolar disorder. Int J Neuropsychopharmacol. 2006;9:83\u20138.","journal-title":"Int J Neuropsychopharmacol"},{"key":"40_CR72","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1016\/j.biopsych.2005.02.019","volume":"57","author":"R Hashimoto","year":"2005","unstructured":"Hashimoto R, Okada T, Kato T, et al. The breakpoint cluster region gene on chromosome 22q11 is associated with bipolar disorder. Biol Psychiatry. 2005;57:1097\u2013102.","journal-title":"Biol Psychiatry"},{"key":"40_CR73","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1038\/ng1235","volume":"35","author":"C Kakiuchi","year":"2003","unstructured":"Kakiuchi C, Iwamoto K, Ishiwata M, et al. Impaired feedback regulation of XBP1 as a genetic risk factor for bipolar disorder. Nature Genet. 2003;35:171\u20135.","journal-title":"Nature Genet"},{"key":"40_CR74","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1097\/FPC.0b013e3282f974ca","volume":"18","author":"G Silberberg","year":"2008","unstructured":"Silberberg G, Levit A, Collier D, et al. Stargazin involvement with bipolar disorder and response to lithium treatment. Pharmacogenet Genomics. 2008;18:403\u201312.","journal-title":"Pharmacogenet Genomics"},{"key":"40_CR75","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/1471-244X-7-9","volume":"7","author":"F Mamdani","year":"2007","unstructured":"Mamdani F, Sequeira A, Alda M, et al. No association between the PREP gene and lithium responsive bipolar disorder. BMC Psychiatry. 2007;7:9.","journal-title":"BMC Psychiatry"},{"key":"40_CR76","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/S0165-0327(99)00173-1","volume":"62","author":"T Kato","year":"2001","unstructured":"Kato T, Kunugi H, Nanko S, et al. Mitochondrial DNA polymorphism in bipolar disorder. J Affect Disord. 2001;62:151\u201364.","journal-title":"J Affect Disord"},{"key":"40_CR77","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1017\/S1461145703003778","volume":"6","author":"S Washizuka","year":"2003","unstructured":"Washizuka S, Ikeda A, Kato N, et al. Possible relationship between mitochondrial DNA polymorphisms and lithium response in bipolar disorder. Int J Neuropsychopharmacol. 2003;6:421\u20134.","journal-title":"Int J Neuropsychopharmacol"},{"key":"40_CR78","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1177\/0269881111415736","volume":"26","author":"JK Rybakowski","year":"2012","unstructured":"Rybakowski JK, Czerski P, Dmitrzak-Weglarz M, et al. Clinical and pathogenic aspects of candidate genes for lithium prophylactic efficacy. J Psychopharmacol. 2012;26:368\u201373.","journal-title":"J Psychopharmacol"},{"key":"40_CR79","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.psychres.2008.05.010","volume":"168","author":"B Kim","year":"2009","unstructured":"Kim B, Kim CY, Lee MJ, et al. Preliminary evidence on the association between XBP1-116C\/G polymorphism and response to prophylactic treatment with valproate in bipolar disorders. Psychiatry Res. 2009;168:209\u201312.","journal-title":"Psychiatry Res"},{"key":"40_CR80","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1097\/00041444-199903000-00005","volume":"9","author":"H Ewald","year":"1999","unstructured":"Ewald H, Wang AG, Vang M, et al. A haplotype-based study of lithium responding patients with bipolar affective disorder on the Faroe Islands. Psychiatr Genet. 1999;9:23\u201334.","journal-title":"Psychiatr Genet"},{"key":"40_CR81","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1038\/sj.mp.4000888","volume":"6","author":"G Turecki","year":"2001","unstructured":"Turecki G, Grof P, Grof E, et al. Mapping susceptibility genes for bipolar disorder: a pharmacogenetic approach based on excellent response to lithium. Mol Psychiatry. 2001;6:570\u20138.","journal-title":"Mol Psychiatry"},{"key":"40_CR82","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1001\/archgenpsychiatry.2007.15","volume":"65","author":"RH Perlis","year":"2008","unstructured":"Perlis RH, Purcell S, Fagerness J, et al. Family-based association study of lithium-related and other candidate genes in bipolar disorder. Arch Gen Psychiatry. 2008;65:53\u201361.","journal-title":"Arch Gen Psychiatry"},{"key":"40_CR83","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1038\/sj.mp.4002012","volume":"13","author":"AE Baum","year":"2008","unstructured":"Baum AE, Akula N, Cabanero M, et al. A genome-wide association study implicates diacylglycerol kinase eta (DGKH) and several other genes in the etiology of bipolar disorder. Mol Psychiatry. 2008;13:197\u2013207.","journal-title":"Mol Psychiatry"},{"key":"40_CR84","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1176\/appi.ajp.2009.08111633","volume":"166","author":"RH Perlis","year":"2009","unstructured":"Perlis RH, Smoller JW, Ferreira MAR, et al. A genome wide association study of response to lithium for prevention of recurrence in bipolar disorder. Am J Psychiatry. 2009;166:718\u201325.","journal-title":"Am J Psychiatry"},{"key":"40_CR85","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.2217\/pgs.11.102","volume":"12","author":"A Squassina","year":"2011","unstructured":"Squassina A, Manchia M, Borg J, et al. Evidence for association of an ACCN1 gene variant with response to lithium treatment in Sardinian patients with bipolar disorder. Pharmacogenomics. 2011;12:1559\u201369.","journal-title":"Pharmacogenomics"},{"key":"40_CR86","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1159\/000314708","volume":"62","author":"TG Schulze","year":"2010","unstructured":"Schulze TG, Alda M, Adli M, et al. The International Consortium on Lithium Genetics (ConLiGen): an initiative by the NIMH and IGSLI to study the genetic basis of response to lithium treatment. Neuropsychobiology. 2010;62:72\u20138.","journal-title":"Neuropsychobiology"},{"key":"40_CR87","unstructured":"Schulze T. The Consortium on Lithium Genetics (ConLiGen) genome-wide association studies of lithium response phenotypes in bipolar disorder [abstract book]. CINP Congress; 3\u20137 June 2012; Stockholm: 36."},{"key":"40_CR88","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1001\/archneur.65.4.550","volume":"65","author":"CA Gurnett","year":"2008","unstructured":"Gurnett CA, Veile R, Zempel J, et al. Disruption of sodium bicarbonate transporter SLC4A10 in a patient with complex partial epilepsy and mental retardation. Arch Neurol. 2008;65:550\u20133.","journal-title":"Arch Neurol"},{"key":"40_CR89","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1002\/ajmg.b.31204","volume":"156B","author":"A Schosser","year":"2011","unstructured":"Schosser A, Gaysina D, Cohen-Woods S, et al. A follow-up case-control association study of tractable (druggable) genes in recurrent major depression. Am J Med Genet B Neuropsychiatr Genet. 2011;156B:640\u201350.","journal-title":"Am J Med Genet B Neuropsychiatr Genet"},{"key":"40_CR90","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1152\/ajpcell.1979.237.1.C102","volume":"237","author":"BE Ehrlich","year":"1979","unstructured":"Ehrlich BE, Diamond JM. Lithium fluxes in human erythrocytes. Am J Physiol. 1979;237:102\u201310.","journal-title":"Am J Physiol"},{"key":"40_CR91","doi-asserted-by":"crossref","first-page":"e32091","DOI":"10.1371\/journal.pone.0032091","volume":"7","author":"MJ McCarthy","year":"2012","unstructured":"McCarthy MJ, Nievergelt CM, Kelsoe JR, et al. A survey of genomic studies supports association of circadian clock genes with bipolar disorder spectrum illnesses and lithium response. PLoS ONE. 2012;7:e32091.","journal-title":"PLoS ONE"}],"container-title":["CNS Drugs"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s40263-013-0040-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40263-013-0040-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40263-013-0040-7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,29]],"date-time":"2023-06-29T04:02:10Z","timestamp":1688011330000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s40263-013-0040-7"}},"subtitle":["Current Status of Knowledge"],"short-title":[],"issued":{"date-parts":[[2013,2,2]]},"references-count":91,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2013,3]]}},"alternative-id":["40"],"URL":"https:\/\/doi.org\/10.1007\/s40263-013-0040-7","relation":{},"ISSN":["1172-7047","1179-1934"],"issn-type":[{"value":"1172-7047","type":"print"},{"value":"1179-1934","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,2,2]]}}}